DTC
SRRA

Deep Track Capital’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Deep Track Capital’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-607,600
Closed -$13.2M – 68
2021
Q4 		$13.2M Buy
+607,600
New +$13.4M 0.93% 38

Other funds holding SRRA

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Deep Track Capital's SRRA Position: Q1 2022 in Review

Deep Track Capital sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q1 2022, closing a stake of 607,600 shares — an estimated $13.2M sold.

Deep Track Capital first reported a position in SRRA in Q4 2021 and held it in 1 quarter. The position peaked at $13.2M in Q4 2021. 75 funds tracked by Wall St. Rank hold SRRA as of Q1 2022.

  • Deep Track Capital reported no remaining Sierra Oncology, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Deep Track Capital sold 607,600 Sierra Oncology, Inc. Common Stock shares in Q1 2022, an estimated $13.2M.
  • Deep Track Capital first reported a position in Sierra Oncology, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Deep Track Capital's Sierra Oncology, Inc. Common Stock position peaked at $13.2M in Q4 2021.
  • 75 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q1 2022.

Based on Deep Track Capital's 13F filing for Q1 2022, filed 16 May 2022.